Efficacy of budesonide/formoterol versus terbutaline plus salmeterol/fluticasone and a fixed maintenance dose of budesonide/formoterol plus terbutaline in patients with asthma

Next Previous
Trial Profile

Efficacy of budesonide/formoterol versus terbutaline plus salmeterol/fluticasone and a fixed maintenance dose of budesonide/formoterol plus terbutaline in patients with asthma

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jan 2018

At a glance

  • Drugs Budesonide/formoterol (Primary) ; Salmeterol/fluticasone propionate; Terbutaline
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms COMPASS

    • Most Recent Events

    • 01 Jan 2018 Results of pooled post-hoc analysis from six studies (STEAM, STEP, STAY, SMILE, COMPASS and AHEAD) published in the European Respiratory Journal.
    • 05 Nov 2010 New trial record.
    • 05 May 2007 Primary endpoint of time to first severe exacerbation has been met, according to results published in the International Journal of Clinical Practice.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top